Your browser doesn't support javascript.
loading
Colicin E1 opens its hinge to plug TolC.
Budiardjo, S Jimmy; Stevens, Jacqueline J; Calkins, Anna L; Ikujuni, Ayotunde P; Wimalasena, Virangika K; Firlar, Emre; Case, David A; Biteen, Julie S; Kaelber, Jason T; Slusky, Joanna S G.
Afiliación
  • Budiardjo SJ; Center for Computational Biology, The University of Kansas, Lawrence, United States.
  • Stevens JJ; Department of Molecular Biosciences, The University of Kansas, Lawrence, United States.
  • Calkins AL; Department of Chemistry, University of Michigan, Ann Arbor, United States.
  • Ikujuni AP; Department of Molecular Biosciences, The University of Kansas, Lawrence, United States.
  • Wimalasena VK; Department of Molecular Biosciences, The University of Kansas, Lawrence, United States.
  • Firlar E; Rutgers CryoEM & Nanoimaging Facility and Institute for Quantitative Biomedicine, Rutgers University, Piscataway, United States.
  • Case DA; Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, United States.
  • Biteen JS; Department of Chemistry, University of Michigan, Ann Arbor, United States.
  • Kaelber JT; Rutgers CryoEM & Nanoimaging Facility and Institute for Quantitative Biomedicine, Rutgers University, Piscataway, United States.
  • Slusky JSG; Center for Computational Biology, The University of Kansas, Lawrence, United States.
Elife ; 112022 02 24.
Article en En | MEDLINE | ID: mdl-35199644
Bacteria are constantly warring with each other for space and resources. As a result, they have developed a range of molecular weapons to poison, damage or disable other cells. For instance, bacteriocins are proteins that can latch onto structures at the surface of enemy bacteria and push toxins through their outer membrane. Bacteria are increasingly resistant to antibiotics, representing a growing concern for modern healthcare. One way that they are able to survive is by using 'efflux pumps' studded through their external membranes to expel harmful drugs before these can cause damage. Budiardjo et al. wanted to test whether bacteriocins could interfere with this defence mechanism by blocking efflux pumps. Bacteriocins are usually formed of binding elements (which recognise specific target proteins) and of a 'killer tail' that can stab the cell. Experiments showed that the binding parts of a bacteriocin could effectively 'plug' efflux pumps in Escherichia coli bacteria: high-resolution molecular microscopy revealed how the bacteriocin fragment binds to the pump, while fluorescent markers showed that it attached to the surface of E. coli and stopped the efflux pumps from working. As a result, lower amounts of antibiotics were necessary to kill the bacteria when bacteriocins were present. The work by Budiardjo et al. could lead to new ways to combat bacteria that will reduce the need for current antibiotics. In the future, bacteriocins could also be harnessed to target other proteins than efflux pumps, allowing scientists to manipulate a range of bacterial processes.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Bacteriocinas / Colicinas / Proteínas de Escherichia coli Idioma: En Revista: Elife Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Bacteriocinas / Colicinas / Proteínas de Escherichia coli Idioma: En Revista: Elife Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos